Janice Wagner to Diabetes Mellitus, Type 2
This is a "connection" page, showing publications Janice Wagner has written about Diabetes Mellitus, Type 2.
Connection Strength
0.850
-
Harwood HJ, Listrani P, Wagner JD. Nonhuman primates and other animal models in diabetes research. J Diabetes Sci Technol. 2012 May 01; 6(3):503-14.
Score: 0.200
-
Wagner JD, Shadoan MK, Zhang L, Ward GM, Royer LJ, Kavanagh K, Francone OL, Auerbach BJ, Harwood HJ. A selective peroxisome proliferator-activated receptor alpha agonist, CP-900691, improves plasma lipids, lipoproteins, and glycemic control in diabetic monkeys. J Pharmacol Exp Ther. 2010 Jun; 333(3):844-53.
Score: 0.172
-
Kavanagh K, Zhang L, Wagner JD. Tissue-specific regulation and expression of heat shock proteins in type 2 diabetic monkeys. Cell Stress Chaperones. 2009 May; 14(3):291-9.
Score: 0.157
-
Kaplan JR, Wagner JD. Type 2 diabetes-an introduction to the development and use of animal models. ILAR J. 2006; 47(3):181-5.
Score: 0.129
-
Gee MK, Zhang L, Rankin SE, Collins JN, Kauffman RF, Wagner JD. Rosiglitazone treatment improves insulin regulation and dyslipidemia in type 2 diabetic cynomolgus monkeys. Metabolism. 2004 Sep; 53(9):1121-5.
Score: 0.118
-
Wagner JD, Carlson CS, O'Brien TD, Anthony MS, Bullock BC, Cefalu WT. Diabetes mellitus and islet amyloidosis in cynomolgus monkeys. Lab Anim Sci. 1996 Feb; 46(1):36-41.
Score: 0.065
-
Kavanagh K, Jones KL, Sawyer J, Kelley K, Carr JJ, Wagner JD, Rudel LL. Trans fat diet induces abdominal obesity and changes in insulin sensitivity in monkeys. Obesity (Silver Spring). 2007 Jul; 15(7):1675-84.
Score: 0.009